Nurix Therapeutics Inc.

NASDAQ: NRIX · Real-Time Price · USD
10.57
0.01 (0.09%)
At close: Aug 15, 2025, 3:59 PM
11.00
4.07%
After-hours: Aug 15, 2025, 05:17 PM EDT

Nurix Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is December - November.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Nov 30, 2024 Nov 30, 2023 Nov 30, 2022 Nov 30, 2021
Net Income
-193.57M -143.95M -180.36M -117.19M
Depreciation & Amortization
16.43M 13.65M 10.81M 6.08M
Stock-Based Compensation
33.93M 33.67M 28.13M 15.8M
Other Working Capital
-23.61M 18.51M -25.11M 6.75M
Other Non-Cash Items
-10.97M -4.87M 636K 1.83M
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
-18.4M 20.12M -19.02M 9.11M
Operating Cash Flow
-172.58M -81.36M -159.81M -84.36M
Capital Expenditures
-9.27M -8.4M -12.24M -5.66M
Cash Acquisitions
n/a n/a -39.44M 102.59M
Purchase of Investments
-707.95M -246.33M -239.37M -348.5M
Sales Maturities Of Investments
459.51M 323.04M 278.81M 245.91M
Other Investing Acitivies
n/a n/a 39.44M -102.59M
Investing Cash Flow
-257.71M 68.3M 27.2M -108.25M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
7.17M 3.22M 97.79M 3.73M
Financial Cash Flow
485.67M 3.22M 117.19M 153.88M
Net Cash Flow
55.37M -9.85M -15.42M -38.73M
Free Cash Flow
-181.86M -89.77M -172.05M -90.03M